Cellectricon
Cellectricon, StressMarq Ink Neurodegenerative Disease Research Deal
Cellectricon is researching the spread of neurodegenerative disease-associated peptides that characterize Alzheimer's disease and Parkinson's disease.
Cellectricon Inks Japan Distribution Deals
NEW YORK (GenomeWeb News) – Cellectricon today said that it has signed agreement with two firms to distribute its products in Japan.
Cellectricon, Fluxion Settle Microfluidic Cellular Analysis IP Dispute
NEW YORK (GenomeWeb News) – Cellectricon and Fluxion Biosciences announced today they have settled a legal dispute dating back to 2009 in which Fluxion was accused of patent infringement.
Fluxion Denies IP Infringement Claims Made by Cellectricon
Cellectricon has resumed an IP infringement suit it initially filed against Fluxion last summer.
Polish University to Use Cellectricon HT System
The University of Lodz will use the system in its gene expression and screening projects.
Apr 27, 2009